Indications and Purposes
| 1 Indications And Usage Evomela Is An Alkylating Drug Indicated For: • Use As A High-Dose Conditioning Treatment Prior To Hematopoietic Progenitor (Stem) Cell Transplantation In Patients With Multiple Myeloma. ( 1.1 ) • The Palliative Treatment Of Patients With Multiple Myeloma For Whom Oral Therapy Is Not Appropriate. ( 1.2 ) 1.1 Multiple Myeloma-Conditioning Treatment Evomela Is Indicated For Use As A High-Dose Conditioning Treatment Prior To Hematopoietic Progenitor (Stem) Cell Transplantation In Patients With Multiple Myeloma. 1.2 Multiple Myeloma-Palliative Treatment Evomela Is Indicated For The Palliative Treatment Of Patients With Multiple Myeloma For Whom Oral Therapy Is Not Appropriate. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Melphalan Hydrochloride |
|
ZINC1673 |